Barreira hematoencefálica (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Barreira hematoencefálica" in Galician language version.

refsWebsite

Global rank Galician rank

18nih.gov

4^th place

6^th place

12doi.org

2^nd place

7^th place

5archive.org

6^th place

8^th place

3worldcat.org

5^th place

11^th place

3web.archive.org

1^st place

1books.google.com

3^rd place

12^th place

1nature.com

234^th place

113^th place

1wiley.com

222^nd place

134^th place

1metapress.com

8,671^st place

6,813^th place

1angiochem.com

low place

1jimmunol.org

low place

4,055^th place

1umdnj.edu

low place

1arizona.edu

1,592^nd place

1,049^th place

angiochem.com

Alfred H. Schinkel. P-Glycoprotein, a gatekeeper in the blood–brain barrier. Advanced Drug Delivery Reviews 36 (1999) 179–194 [5]

archive.org

Gilgun-Sherki, Yossi; Melamed, Eldad; Offen, Daniel (2001). "Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier". Neuropharmacology 40 (8): 959–975. ISSN 0028-3908. PMID 11406187. doi:10.1016/S0028-3908(01)00019-3.
Tortora, Gerard J.; Berdell R. Funke, Christine L. Case (2010). Benjamin Cummings, ed. Microbiology: An Introduction. San Francisco. pp. 439, 611. ISBN 0-321-55007-2.
Tortora, Gerard J.; Berdell R. Funke, Christine L. Case (2010). Benjamin Cummings, ed. Microbiology: An Introduction. San Francisco. pp. 616-618. ISBN 0-321-55007-2.
Tortora, Gerard J.; Berdell R. Funke, Christine L. Case (2010). Benjamin Cummings, ed. Microbiology: An Introduction. San Francisco. pp. 615. ISBN 0-321-55007-2.
Klepper, J; Voit T (2002). "Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain—a review". European journal of pediatrics 161 (6): 295–304. PMID 12029447. doi:10.1007/s00431-002-0939-3.

arizona.edu

davislab.med.arizona.edu

History of the Blood-Brain Barrier Arquivado 25 de abril de 2012 en Wayback Machine. by T.J. Davis. Department of Pharmacology, University of Arizona, Tucson, United States

books.google.com

Pritchard, Thomas C.; Alloway, Kevin Douglas (1999). Medical Neuroscience (Google books preview). Hayes Barton Press. pp. 76–77. ISBN 1889325295. Consultado o 2009-02-08.

doi.org

dx.doi.org

Hamilton RD, Foss AJ, Leach L (2007). "Establishment of a human in vitro model of the outer blood–retinal barrier". Journal of Anatomy 211 (6): 707–16. PMC 2375847. PMID 17922819. doi:10.1111/j.1469-7580.2007.00812.x.
Gilgun-Sherki, Yossi; Melamed, Eldad; Offen, Daniel (2001). "Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier". Neuropharmacology 40 (8): 959–975. ISSN 0028-3908. PMID 11406187. doi:10.1016/S0028-3908(01)00019-3.
Silva, GA (2008). "Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS". BMC Neuroscience 9: S4. PMC 2604882. PMID 19091001. doi:10.1186/1471-2202-9-S3-S4.
Brigger I, Morizet J, Aubert G; et al. (2002). "Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting". J. Pharmacol. Exp. Ther. 303 (3): 928–36. PMID 12438511. doi:10.1124/jpet.102.039669.
Hashizume, H; Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM (2000). "Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness". American Journal of Pathology 156 (4): 1363–1380. PMC 1876882. PMID 10751361. doi:10.1016/S0002-9440(10)65006-7.
Schneider, SW; Ludwig T, Tatenhorst L, Braune S, Oberleithner H, Senner V, Paulus W (2004). "Glioblastoma cells release factors that disrupt blood–brain barrier features". Acta Neuropathologica 107 (3): 272–276. PMID 14730455. doi:10.1007/s00401-003-0810-2.
Oby, Emily; Janigro, Damir (2006). "The Blood–Brain Barrier and Epilepsy" (PDF). Epilepsia 47 (11): 1761–1774. ISSN 0013-9580. PMID 17116015. doi:10.1111/j.1528-1167.2006.00817.x.
Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O; et al. (2007). "TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis". Brain 130 (Pt 2): 535–47. PMID 17121744. doi:10.1093/brain/awl317.
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005). "IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel". J. Exp. Med. 202 (4): 473–7. PMC 2212860. PMID 16087714. doi:10.1084/jem.20050304.
Pascual, JM; Wang D, Lecumberri B, Yang H, Mao X, Yang R, De Vivo DC (2004). "GLUT1 deficiency and other glucose transporter diseases". European journal of endocrinology 150 (5): 627–33. PMID 15132717. doi:10.1530/eje.0.1500627.
Klepper, J; Voit T (2002). "Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain—a review". European journal of pediatrics 161 (6): 295–304. PMID 12029447. doi:10.1007/s00431-002-0939-3.
Williams, Kenneth C.; Hickey, William F. (2002). "Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS". Annual Review of Neuroscience 25 (1): 537–562. ISSN 0147-006X. PMID 12052920. doi:10.1146/annurev.neuro.25.112701.142822.

jimmunol.org

Schreibelt G, Musters RJ, Reijerkerk A; et al. (2006). "Lipoic acid affects cellular migration into the central nervous system and stabilizes blood–brain barrier integrity". J. Immunol. 177 (4): 2630–7. PMID 16888025.

metapress.com

iospress.metapress.com

Waubant E (2006). "Biomarkers indicative of blood–brain barrier disruption in multiple sclerosis". Disease Markers 22 (4): 235–44. PMID 17124345. Arquivado dende o orixinal o 01 de agosto de 2020. Consultado o 02 de abril de 2012.

nature.com

Kwang Sik Kim. Mechanisms of microbial traversal of the blood–brain barrier. Nature Reviews Microbiology 6, 625-634 (August 2008). doi:10.1038/nrmicro1952 [2]

nih.gov

ncbi.nlm.nih.gov

Hamilton RD, Foss AJ, Leach L (2007). "Establishment of a human in vitro model of the outer blood–retinal barrier". Journal of Anatomy 211 (6): 707–16. PMC 2375847. PMID 17922819. doi:10.1111/j.1469-7580.2007.00812.x.
Gilgun-Sherki, Yossi; Melamed, Eldad; Offen, Daniel (2001). "Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier". Neuropharmacology 40 (8): 959–975. ISSN 0028-3908. PMID 11406187. doi:10.1016/S0028-3908(01)00019-3.
Dennis J. Grab, George Perides, J. Stephen Dumler, Kee Jun Kim, Jinho Park, Yuri V. Kim, Olga Nikolskaia, Kyoung Seong Choi, Monique F. Stins, and Kwang Sik Kim. Borrelia burgdorferi, Host-Derived Proteases, and the Blood-Brain Barrier. Infect Immun. 2005 February; 73(2): 1014–1022. doi: 10.1128/IAI.73.2.1014-1022.2005 PMCID: PMC546937. [1]
Virgintino D, Errede M, Girolamo F, Capobianco C, Robertson D, Vimercati A, Serio G, Di Benedetto A, Yonekawa Y, Frei K, Roncali L. Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol. 2008 Jan;67(1):50-61. [3] PMID 18091560
Braun LD, Cornford EM, Oldendorf WH. Newborn rabbit blood-brain barrier is selectively permeable and differs substantially from the adult. J Neurochem. 1980 Jan;34(1):147-52. [4] PMID 7452231
Silva, GA (2008). "Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS". BMC Neuroscience 9: S4. PMC 2604882. PMID 19091001. doi:10.1186/1471-2202-9-S3-S4.
Brigger I, Morizet J, Aubert G; et al. (2002). "Poly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targeting". J. Pharmacol. Exp. Ther. 303 (3): 928–36. PMID 12438511. doi:10.1124/jpet.102.039669.
Hashizume, H; Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM (2000). "Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness". American Journal of Pathology 156 (4): 1363–1380. PMC 1876882. PMID 10751361. doi:10.1016/S0002-9440(10)65006-7.
Schneider, SW; Ludwig T, Tatenhorst L, Braune S, Oberleithner H, Senner V, Paulus W (2004). "Glioblastoma cells release factors that disrupt blood–brain barrier features". Acta Neuropathologica 107 (3): 272–276. PMID 14730455. doi:10.1007/s00401-003-0810-2.
Beam, TR Jr.; Allen, JC (1977). "Blood, Brain, and Cerebrospinal Fluid Concentrations of Several Antibiotics in Rabbits with Intact and Inflamed Meninges". Antimicrobial agents and chemotherapy 12 (6): 710–6. PMC 430009. PMID 931369.
Oby, Emily; Janigro, Damir (2006). "The Blood–Brain Barrier and Epilepsy" (PDF). Epilepsia 47 (11): 1761–1774. ISSN 0013-9580. PMID 17116015. doi:10.1111/j.1528-1167.2006.00817.x.
Ivens S, Kaufer D, Flores LP, Bechmann I, Zumsteg D, Tomkins O; et al. (2007). "TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis". Brain 130 (Pt 2): 535–47. PMID 17121744. doi:10.1093/brain/awl317.
Waubant E (2006). "Biomarkers indicative of blood–brain barrier disruption in multiple sclerosis". Disease Markers 22 (4): 235–44. PMID 17124345. Arquivado dende o orixinal o 01 de agosto de 2020. Consultado o 02 de abril de 2012.
Schreibelt G, Musters RJ, Reijerkerk A; et al. (2006). "Lipoic acid affects cellular migration into the central nervous system and stabilizes blood–brain barrier integrity". J. Immunol. 177 (4): 2630–7. PMID 16888025.
Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR (2005). "IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel". J. Exp. Med. 202 (4): 473–7. PMC 2212860. PMID 16087714. doi:10.1084/jem.20050304.
Pascual, JM; Wang D, Lecumberri B, Yang H, Mao X, Yang R, De Vivo DC (2004). "GLUT1 deficiency and other glucose transporter diseases". European journal of endocrinology 150 (5): 627–33. PMID 15132717. doi:10.1530/eje.0.1500627.
Klepper, J; Voit T (2002). "Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain—a review". European journal of pediatrics 161 (6): 295–304. PMID 12029447. doi:10.1007/s00431-002-0939-3.
Williams, Kenneth C.; Hickey, William F. (2002). "Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS". Annual Review of Neuroscience 25 (1): 537–562. ISSN 0147-006X. PMID 12052920. doi:10.1146/annurev.neuro.25.112701.142822.

umdnj.edu

Nagele, Robert G. (2006). "Alzheimer's disease: new mechanisms for an old problem". University of Medicine and Dentistry of New Jersey. Arquivado dende o orixinal o 17 de setembro de 2011. Consultado o 2011-07-22.

web.archive.org

Waubant E (2006). "Biomarkers indicative of blood–brain barrier disruption in multiple sclerosis". Disease Markers 22 (4): 235–44. PMID 17124345. Arquivado dende o orixinal o 01 de agosto de 2020. Consultado o 02 de abril de 2012.
Nagele, Robert G. (2006). "Alzheimer's disease: new mechanisms for an old problem". University of Medicine and Dentistry of New Jersey. Arquivado dende o orixinal o 17 de setembro de 2011. Consultado o 2011-07-22.
History of the Blood-Brain Barrier Arquivado 25 de abril de 2012 en Wayback Machine. by T.J. Davis. Department of Pharmacology, University of Arizona, Tucson, United States

wiley.com

onlinelibrary.wiley.com

Oby, Emily; Janigro, Damir (2006). "The Blood–Brain Barrier and Epilepsy" (PDF). Epilepsia 47 (11): 1761–1774. ISSN 0013-9580. PMID 17116015. doi:10.1111/j.1528-1167.2006.00817.x.

worldcat.org

Gilgun-Sherki, Yossi; Melamed, Eldad; Offen, Daniel (2001). "Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier". Neuropharmacology 40 (8): 959–975. ISSN 0028-3908. PMID 11406187. doi:10.1016/S0028-3908(01)00019-3.
Oby, Emily; Janigro, Damir (2006). "The Blood–Brain Barrier and Epilepsy" (PDF). Epilepsia 47 (11): 1761–1774. ISSN 0013-9580. PMID 17116015. doi:10.1111/j.1528-1167.2006.00817.x.
Williams, Kenneth C.; Hickey, William F. (2002). "Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS". Annual Review of Neuroscience 25 (1): 537–562. ISSN 0147-006X. PMID 12052920. doi:10.1146/annurev.neuro.25.112701.142822.